Menu
Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 14
Retraction
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,017 | Dovepress* | 2,758+ | 460 | 3,218 | |
| PubMed Central* | 259 | 35 | 294 | ||
| Totals | 3,017 | 495 | 3,512 | ||
| *Since 3 March 2021 | |||||
View citations on PubMed Central and Google Scholar